Device sponsor, consultant give insider look at industry

August 2009
Clinical Trials Administrator;Aug2009, Vol. 7 Issue 8, p91
The article focuses on the views of Deborah Schenberger, a research analyst for Nerac, and Kathi Durdon, an associate from Welch Allyn Inc., on marketing clinical trials to clinical research (CR) sites by medical device companies. Schenberger cites federal regulatory attention paid to relationships between orthopedic surgeons and device companies as one problem in finding sites. Durdon explains the differences between device and pharmaceutical trials. According to Durdon, clinical trial is the best way to test usability and customer preference.


Related Articles

  • Device company expert discusses what sponsor needs to hear from PIs.  // Clinical Trials Administrator;Aug2009, Vol. 7 Issue 8, p92 

    The article provides tips for clinical trial sites who want to expand to medical devices studies, given by Kathi Durdon, clinical operations associate with Welch Allyn Inc. These include showing interest in device research, being open to small studies, and working with populations of...

  • Doctor Doom. Andersen, Steven // InsideCounsel;Oct2010, Vol. 22 Issue 225, p36 

    The article discusses pharmaceutical companies' vulnerability to violate the Foreign Corrupt Practices Act (FCPA) in the U.S. Drug and medical device manufacturers are prone to FCPA violations because many clinical trials are performed overseas. Many of drugs approved in the U.S. are derived...

  • MDUFMA II Should Address Pre-IDE Process--stakeholders.  // Medical Design Technology;Dec2005, Vol. 9 Issue 13, p8 

    The article reports on the third annual MDUFMA stakeholder meeting held on November 17, 2005 which focused on the need for improvement in the process by which medical equipment companies and the FDA negotiate clinical trial designs. It has been observed that current performance goals under the...

  • So your site would like to try a device trial?  // Clinical Trials Administrator;Aug2009, Vol. 7 Issue 8, p89 

    The article presents pieces of advice from experts on marketing the clinical research site for medical device trials. Patricia Larrabee, chief executive officer (CEO) of Rochester Clinical Research Inc. suggests to develop potential, starting with staff training. Deborah Schenberger of Nerac...

  • PRODUCT BRIEFS.  // Medical Device Daily;5/20/2009, Vol. 13 Issue 96, p12 

    This section offers news briefs in the medical device industry. The Naval Medical Research Center (NMRC) has been advised by the U.S. Food and Drug Administration (FDA) to cancel its planned clinical trial of the Hemopire oxygen therapeutic. Commercial retail sales of the Generex Oral-lyn oral...

  • Product Briefs.  // Medical Device Daily;2/10/2012, Vol. 16 Issue 28, p10 

    This section offers news briefs on the medical device industry in the U.S. Endologix received Food & Drug Administration (FDA) approval for its percutaneous EVAR (PEVAR) clinical trial. A comprehensive operations summary was released by NanoLogix that revealed an exponential drop in detection...

  • Product Briefs.  // Medical Device Daily;2/13/2012, Vol. 16 Issue 29, p7 

    This section offers news briefs on the U.S. medical device industry, including the development of the Precice Limb Lengthening System by orthopedic surgeons Shawn Standard and John Herzenberg of Sinai Hospital in Baltimore, Maryland, and the phase III clinical study of the DeNovo ET Engineered...

  • Medtronic launches pacemaker trial for use in MRI machines.  // Medical Device Daily;1/29/2008, Vol. 12 Issue 19, p10 

    The article reports on the commence of a U.S. clinical trial by Medtronic to confirm the safety and efficacy of the EnRhythm MRI SureScan pacing system. The pacing system consist of the dual-chamber SureScan pacemaker and CapSureFix MRI SureScan pacing leads. Pat Mackin, president of the...

  • Top 5 Partnering Mistakes. Reese, Brenda // Applied Clinical Trials;2010 Partnerships Supplement, p6 

    The article focuses on the author's view on several mistakes made by pharmaceutical, medical device and biotech companies in choosing a clinical research organization (CRO) partner. She mentions that dealing with CRO partnership one must base on facts rather than perception. She highlights...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics